β-lactam and macrolide resistance and serotype distribution among Streptococcus pneumoniae isolates from Saudi Arabia

Journal of Chemotherapy

Volumn 16, Issue 6, 2004, Pages 517-523

  Fouda, S I ^a   Kadry, Ashraf A ^a,b   Shibl, A M ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

E test; Macrolide resistance mechanism; Serotyping; Streptococcus pneumoniae; lactam and macrolide resistance

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CEFACLOR; CEFDINIR; CEFIXIME; CEFPROZIL; CEFTRIAXONE; CEFUROXIME; CLARITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; MACROLIDE; OXACILLIN; PENICILLIN G; ROXITHROMYCIN; SPIRAMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SAUDI ARABIA; SEROTYPE; STREPTOCOCCUS PNEUMONIAE;

EID: 12544254303     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2004.16.6.517     Document Type: Article

References (40)

1. Appelbaum PC. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis 1992; 15: 77-83.
2. Musher DM. Streptococcus pneumoniae; in Mandell G, Bennett JE, Dolin R (eds): Principles and Practice of Infectious Diseases, ed 4. Churchill Livingstone Inc., New York, 1995, pp 1811-1826.
3. Garenne MM, Ronsmaus C. The magnitude of mortality from acute respiratory infections in children under 5 years in developing countries. World Health Stat. Q 1992; 45: 180-191.
4. Latorre C, Juncosa T, Sanfeliu I. Antibiotic resistance and serotypes of 100 Streptococcus pneumoniae strains isolated in a children's hospital in Barcelona, Spain. Antimicrob Agents Chemother 1985; 28: 357-359.
5. Lyon DJ, Scheel O, Fung KS, Cheng AF, Henrichsen J. Rapid emergence of penicillin-resistant pneumococci in Hong Kong. Scand J Infect Dis 1996; 28: 375-376.
6. Fung C-P, Hu B-S, Lee S-C, Liu PY-F et al. Antimicrobial resistance of Streptococcus pneumoniae isolated in Taiwan: an island-wide surveillance study between 1996 and 1997. J Antimicrob Chemother 2000; 45: 49-55.
7. Eanie LM, Visalli MA, Jacobs MR, Appelbaum PC. Comparative activities of clarithromycin, erythromycin, and azithromycin against penicillin-susceptible and penicillin resistant pneumococci. Antimicrob Agents Chemother 1996; 40: 1950-1952.
8. Felmingham D, Gruneberg RN, The Alexander Project Group. A multicenter collaborative study of the antimicrobial susceptibility of community-acquired, lower respiratory tract pathogens 1992-1993: The Alexander Project. J Antimicrob Chemother 1996; 38: 1-57.
9. Malmborg A-S. The resistance of erythromycin. J Antimicrob Chemother 1986; 18: 293-299.
10. Leclercq R, Courvalin P. Bacterial resistance to macrolide, lincosamide and streptogramin antibiotics by target modification. Antimicrob Agents Chemother 1991; 35: 1267-1272.
11. Sutcliffe J, Tait-Kamradt A, Wondrack L. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob Agents Chemother 1996; 40: 1817-1824.
12. Butler JC, Lennox JL, McDougal LK, Sutcliffe JA et al. Macrolide-resistant pneumococcal endocarditis and epidural abscess that develop during erythromycin therapy. Clin Infect Dis 2003; 36: e19-e25.
13. Tait-Kamradt A, Clancy J, Cronan M, Dib-Hajj F et al. mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae. Antimicrob Agents Chemother 1997; 41: 2251-2255.
14. Henrichsen J. Six newly recognized types of Streptococcus pneunumiae. J Clin Microbiol 1995; 33: 2759-2762.
15. Lafong AC, Crothers E. Simple latex agglutination method for typing pneumococci. J Clin Pathol 1988; 41: 230-231.
16. Ruoff KL, Whiley RA, Beighton D. Streptococcus; in Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, (eds): Mannual of Clinical Microbiology, ed 7., American Society for Microbiology, Washington, 1999: 283-296.
17. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk Susceptibility Test-Eighth Edition. Approved Standard M2-A8. NCCLS, Wayne, Pa 2003.
18. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically- Sixth Edition: Approved Standard M7-A6. NCCLS, Wayne, Pa, 2003.
19. Arai S, konda T, Wada A, Matsunaga Y et al. Use of antiserum-coated latex particles for serotyping Streptococcus pneumoniae. Microbiol Immunol 2001; 45: 159-162.
20. Morosini M-I, Canton R, Loza E, et al. In vitro activity of telithromycin against Spanish streptococcus pneumoniae isolates with characterized macrolide resistance mechanisms. Antimicrob Agents Chemother 2001; 45: 2427-2431.
21. Shortridge VD, Flamm RK, Ramer N, Beyer J, Tanaka SK. Novel mechanism of macrolide resistance in Streptococcus pneumoniae. Diagn Microbiol Infect Dis 1996; 26: 73-78.
22. Barlett JG, Breiman RF, Mandell LA, File TM. Community-acquired pneumonia in adults: guidelines for management. Clin Infect Dis 1998; 26: 811-838.
23. Swenson JM, Hill BC, Thornsberry C. Screening pneumococci for penicillin resistance. J Clin Microbiol 1986; 24: 749-752.
24. Felmingham D, Tesfaslasie Y, Burley C, Masterton RG. Penicillin resistance in pneumococci. J Antimicrob Chemother 2000; 45: 710-711.
25. Lee HJ, Park JY, Jang SH, Kim JH, Kim EC, Choi KW. High incidence of resistance to multiple antimicrobials in clinical isolates of Streptococcus pneumoniae from a university hospital in Korea. Clin Infect Dis 1995; 20: 826-835.
26. Mahgoub E-S, Hussein SS. Streptococcus pneumoniae serotypes and their minimal inhibitory concentration to penicillin in Riyadh. SMJ 1986; 7: 149-154.
27. Shibl AM, Hussein SS, Bahakime HM, Sofan MM. Activity of penicillin, imipenem and teicoplanin against various serotypes of Streptococcus pneumoniae isolated in Riyadh. In Progress in Antimicrobial and Anticancer Chemotherapy, Antimicrobial Section I. Proceedings of the 15th. International Congress of Chemotherapy, Istanbul, 1987, Berkarda B, Kuemmerle H-P (eds), Ecomed, Landsberg/Lech, Germany, 1987: 757-759.
28. Shibl AM, Hussein SS, Sofan MM. Surveillance of Streptococcus pneumoniae serotypes existing in Riyadh and their antimicrobial susceptibility patterns. In 2nd International Congress of Hospital Infections, London. Abstract No. 13/1, 1990: 151.
29. Shibl AM, Hussein SS. Surveillance of Streptococcus pneumoniae serotypes in Riyadh and their susceptibility to penicillin and other commonly prescribed antibiotics. J Antimicrob Chemother 1992; 29: 149-157.
30. Shibl AM, Al-Rasheed AM, El Basier AM, Osoba AO. Penicillin-resistant and -intermediate Streptococcus pneumoniae in Saudi Arabia. J Chemother 2000; 12: 134-137.
31. Lagrou K, Peetermans WE, Verhaegen J, Van Lierde S, Verbist L, Van EIdere J. Macrolide resistance in Belgian streptococcus pneumoniae. J Antimicrob Chemother 2000; 45: 119-121.
32. Verhaegen J, Verbist L. In-vitro activities of 16 non-β-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae. J Antimicrob Chemother 1999; 43: 563-567.
33. Baquero F, Garcia-Rodriguez JA, Garcia de-Lomas J, Aguilar L, the Spanish Surveillance Group for Respiratory Tract Pathogens. Antimicrobial resistance of 1,113 Streptococcus pneumoniae isolates from patients with respiratory tract infection in Spain: results of a 1-year (1996-1997) multicenter surveillance study. Antimicrob Agents Chemother 1999; 43: 357-359.
34. Johnston NJ, De AJ, Kellner JD, Low DE. Prevalence and characterization of the mechanisms of macrolide, lincosamide and streptogramin resistance in isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother 1998; 42: 2425-2426.
35. Nishijima T, Saito Y, Aoki A, Toriya M, Toyonaga Y, Fuji R. Distribution of mefE and ermB genes in macrolide-resistant strains of Streptococcus pneumoniae and their variable susceptibility to various antibiotics. J Antimicrob Chemother 1999; 43: 637-643.
36. Montanari MP, Mingoia M, Giovanetti E, Varaldo PE. Differentiation of resistance phenotypes among erythromycin-resistant pneumococci. J Clin Microbiol 2001; 39: 1311-1315.
37. Shortridge VD, Doern GV, Brueggemann AB, Beyer JM, Flamm RK. Prevalence of macrolide resistance mechanisms in Streptococcus pneumoniae isolates from a multicenter antibiotic resistance surveillance study conducted in the United States in 1994-1995. Clin Infect Dis 1999; 29: 1186-1188.
38. Felmingham D, Gruneberg RN. The Alexander Project 1996-1997:latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections. J Antimicrob Chemother 2000; 45: 191-203.
39. Gordon SB, Kanyanda S, Walsh AL, et al. Poor potential coverage for 7-valent pneumococcal conjugate vaccine, Malawi. Emerg Infect Dis 2003; 9: 747-749.
40. Shann F. Pneumococcus and influenza. Lancet 1990; 335: 898-901.